Literature DB >> 16458606

Langerhans cells--revisiting the paradigm using genetically engineered mice.

Adrien Kissenpfennig1, Bernard Malissen.   

Abstract

Langerhans cells (LCs) are prominent dendritic cells (DCs) in epithelia, but their role in immunity and tolerance is poorly defined. 'Knockin' mice expressing enhanced green fluorescent protein (EGFP) under the control of the langerin (CD207) gene were recently developed in order to discriminate epidermal LCs from other DC subsets and at the same time to track their dynamics under steady-state or inflammatory conditions in vivo. Additional knockin mice expressing a diphtheria toxin receptor fused to EGFP were used to conditionally ablate LCs and assess their role in triggering hapten-specific T cell effectors through skin immunization. We review the insights that have been provided by these various knockin mice and discuss gaps in our knowledge of LCs that need to be filled.

Entities:  

Mesh:

Year:  2006        PMID: 16458606     DOI: 10.1016/j.it.2006.01.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  21 in total

Review 1.  Professional antigen-presenting cells of the skin.

Authors:  Alicia R Mathers; Adriana T Larregina
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.

Authors:  Rebecca J Dearman; Marie Cumberbatch; Gavin Maxwell; David A Basketter; Ian Kimber
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

3.  Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.

Authors:  Vincent Flacher; Christoph H Tripp; Bernhard Haid; Adrien Kissenpfennig; Bernard Malissen; Patrizia Stoitzner; Juliana Idoyaga; Nikolaus Romani
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

4.  Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues.

Authors:  Simone Meuter; Patrick Schaerli; Regula Stuber Roos; Oliver Brandau; Michael R Bösl; Ulrich H von Andrian; Bernhard Moser
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

5.  An epithelial organoid model with Langerhans cells for assessing virus-host interactions.

Authors:  Robert Jackson; Statton Eade; Ingeborg Zehbe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

6.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice.

Authors:  Diana L Vesely; Durland Fish; Mark J Shlomchik; Daniel H Kaplan; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

8.  Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.

Authors:  Vincent Flacher; Christoph H Tripp; Patrizia Stoitzner; Bernhard Haid; Susanne Ebner; Barbara Del Frari; Franz Koch; Chae Gyu Park; Ralph M Steinman; Juliana Idoyaga; Nikolaus Romani
Journal:  J Invest Dermatol       Date:  2009-11-05       Impact factor: 8.551

9.  Migration of skin dendritic cells in response to ionizing radiation exposure.

Authors:  Ryan J Cummings; Soumya Mitra; Thomas H Foster; Edith M Lord
Journal:  Radiat Res       Date:  2009-06       Impact factor: 2.841

Review 10.  Intravital Imaging Techniques for Biomedical and Clinical Research.

Authors:  Anouchka Coste; Maja H Oktay; John S Condeelis; David Entenberg
Journal:  Cytometry A       Date:  2019-12-30       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.